ISPOR Europe 2024 17-20 November
The Visible Analytics team will be in Barcelona and looks forward to meeting you there.
Come meet us at our booth 1506 and join us at one of our sessions.
See our full list of activities for ISPOR Europe 2024 below or download our Visible Analytics conference brochure
Monday 18 November
Should We Account for Variation in Patient Preferences in Health Technology Assessment? Individual Preferences With Respect to the Characteristics and Possible Outcomes of a Healthcare Intervention May Vary [107]
Moderator: Amanda Ingham Adler, MD, PhD, FRCP, Diabetes Trials Unit | OCDEM, Churchill Hospital, Oxford, UK
Panellists: Shelagh Szabo, MSc, Broadstreet Health Economics & Outcomes Research, Vancouver, Canada; Ben A Van Hout, PhD, ScHARR, University of Sheffield, UK; Neil Hawkins, MSc, PhD, MBA, CStat, Institute of Health and Wellbeing, University of Glasgow, UK
10:15 - 11:15 Breakout session
Graphing the Second Sex: Evidence for a Male-First Preference for Data Displays in Studies of Health-Related Quality of Life From 2003 to 2024 [MSR13]
Manalastas E1, Angdembe A1, Hegarty P2
1Visible Analytics Ltd, 2The Open University, Milton Keynes, UK
Poster session 1
12:30 - 13:30 Discussion period
Joint Meta-Analysis of Two Diagnostic Tests Using Bivariate Copulas to Model Within-Study Dependencies in Health Technology Assessment (HTA) of Novel Biomarkers in Alzheimer’s Disease Dementia [SA2]
Sheppard A1, Papanikos A2, Quinn T3, Abrams K4, Bujkiewicz S5, Owen R6
1Swansea University, UK, 2GlaxoSmithKline, Ware, UK, 3University of Glasgow, UK, 4University of Warwick and University of York, UK, 5University of Leicester, UK, 6Swansea University, UK
Poster session 1
12:30 - 13:30 Discussion period
Retractions of Health Economic Models: A Systematic Review [EE223]
Manalastas EJ, Thompson JC, Hombali A, Scott DA
Poster session 2
18:00 – 19:00 Discussion period
Sex/Gender Equity Considerations in Clinical Trials of Gepants for Migraine: A Systematic Review [SA26]
Angdembe A, Manalastas EJ
Poster session 2
18:00 – 19:00 Discussion period
Preprint Servers: The Purgatory of Peer-Reviewed Publications? [SA37]
Thompson JC, Manalastas E, Hombali A, Scott DA
Poster session 2
18:00 – 19:00 Discussion period
A Simulation Study Comparing the Performance of the Linear Regression, Daniel and Hughes, and Bivariate Random Effect Meta-Analysis (BRMA) Models of Surrogacy Relationships for Treatment Effects [MSR75]
Hawkins N
University of Glasgow, UK
Poster session 2
18:00 – 19:00 Discussion period
Evaluating Amyloid-Beta as a Surrogate Endpoint for Cognitive Function in Alzheimer’s Disease: A Bayesian Hierarchical Meta-Analysis of Randomized Controlled Trials of Anti-Amyloid Monoclonal Antibodies [SA48]
Ren S1, Singh J2, Gsteiger S3, Reed B4, Cogley CM4, Abrams K5, Dawoud D6, Owen R7, Tappenden P1, Quinn T8, Bujkiewicz S4
1University of Sheffield, UK, 2University of Leicester, UK, 3F. Hoffmann-La Roche Ltd, Switzerland, 4University of Leicester, UK, 5University of Warwick and University of York, UK, 6National Institute for Health and Care Excellence, London, UK, 7Swansea University, UK, 8University of Glasgow, UK
Poster session 2
18:00 – 19:00 Discussion period
Tuesday 19 November
Comparative Effectiveness of Echinocandins in the Treatment of Invasive Candidiasis: A Systematic Review and Network Meta-Analysis [CO145]
Linsell L1, Thompson JC1, Manalastas E1, Dickerson S2, Bielicka I3
1Visible Analytics Ltd, 2Mundipharma Ltd, Cambridge, UK, 4Mundipharma Ltd, Warsaw, Poland
Poster session 4
18:00 – 19:00 Discussion period
Understanding Heterogeneity in Patient Preferences for Psoriasis Treatments: A Qualitative Grounded Theory Study [PCR251]
Szabo S, Hawkins N, Germeni E
University of Glasgow, UK
Poster session 4
18:00 – 19:00 Discussion period
